| 1 | relaxation of smooth muscle (GO:0044557) | 8.62593842 |
| 2 | rRNA catabolic process (GO:0016075) | 8.18318039 |
| 3 | sphingosine metabolic process (GO:0006670) | 7.71253907 |
| 4 | cGMP-mediated signaling (GO:0019934) | 7.30293598 |
| 5 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 7.21250097 |
| 6 | regulation of mitochondrial translation (GO:0070129) | 7.08151333 |
| 7 | diol metabolic process (GO:0034311) | 6.96548298 |
| 8 | sphingoid metabolic process (GO:0046519) | 6.29189656 |
| 9 | negative regulation of leukocyte chemotaxis (GO:0002689) | 6.26389652 |
| 10 | positive regulation of histone deacetylation (GO:0031065) | 5.90847323 |
| 11 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 5.90551242 |
| 12 | ceramide catabolic process (GO:0046514) | 5.86663709 |
| 13 | motile cilium assembly (GO:0044458) | 5.66649730 |
| 14 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 5.48151981 |
| 15 | negative regulation by host of viral transcription (GO:0043922) | 5.42277197 |
| 16 | regulation of platelet aggregation (GO:0090330) | 5.31153842 |
| 17 | positive regulation by host of viral transcription (GO:0043923) | 5.26953913 |
| 18 | white fat cell differentiation (GO:0050872) | 5.26487224 |
| 19 | water-soluble vitamin biosynthetic process (GO:0042364) | 5.19503580 |
| 20 | synaptic transmission, cholinergic (GO:0007271) | 4.88480766 |
| 21 | negative regulation of telomere maintenance (GO:0032205) | 4.78197355 |
| 22 | negative regulation of histone acetylation (GO:0035067) | 4.77681965 |
| 23 | negative regulation of smooth muscle contraction (GO:0045986) | 4.70005836 |
| 24 | negative regulation of platelet activation (GO:0010544) | 4.65915536 |
| 25 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.56492075 |
| 26 | ncRNA catabolic process (GO:0034661) | 4.49574060 |
| 27 | kynurenine metabolic process (GO:0070189) | 4.34083602 |
| 28 | negative regulation of telomerase activity (GO:0051974) | 4.30541102 |
| 29 | positive regulation of protein deacetylation (GO:0090312) | 4.29499664 |
| 30 | negative regulation of cell cycle arrest (GO:0071157) | 4.19972667 |
| 31 | regulation of histone deacetylation (GO:0031063) | 4.19871513 |
| 32 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.12634405 |
| 33 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.07109104 |
| 34 | regulation of respiratory system process (GO:0044065) | 4.04134578 |
| 35 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.98975631 |
| 36 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.92725447 |
| 37 | adaptation of signaling pathway (GO:0023058) | 3.90601062 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.88928327 |
| 39 | positive regulation of T cell apoptotic process (GO:0070234) | 3.88705451 |
| 40 | positive regulation of interleukin-17 production (GO:0032740) | 3.87854891 |
| 41 | N-glycan processing (GO:0006491) | 3.81843840 |
| 42 | membrane repolarization during action potential (GO:0086011) | 3.80090374 |
| 43 | mesenchymal cell differentiation (GO:0048762) | 3.76663645 |
| 44 | regulation of skeletal muscle contraction (GO:0014819) | 3.72837683 |
| 45 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.72715245 |
| 46 | protein localization to cilium (GO:0061512) | 3.72314319 |
| 47 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.70879679 |
| 48 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.70579619 |
| 49 | regulation of mesoderm development (GO:2000380) | 3.67657367 |
| 50 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.62342274 |
| 51 | cellular response to dexamethasone stimulus (GO:0071549) | 3.59780343 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.58902596 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 3.58902596 |
| 54 | tryptophan catabolic process (GO:0006569) | 3.58902596 |
| 55 | cell differentiation involved in kidney development (GO:0061005) | 3.54650719 |
| 56 | response to pH (GO:0009268) | 3.47837833 |
| 57 | negative regulation of protein acetylation (GO:1901984) | 3.44342225 |
| 58 | iron-sulfur cluster assembly (GO:0016226) | 3.44330781 |
| 59 | metallo-sulfur cluster assembly (GO:0031163) | 3.44330781 |
| 60 | relaxation of muscle (GO:0090075) | 3.37894567 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 3.36674146 |
| 62 | adipose tissue development (GO:0060612) | 3.35732588 |
| 63 | regulation of hippo signaling (GO:0035330) | 3.33760881 |
| 64 | response to dexamethasone (GO:0071548) | 3.32201648 |
| 65 | peptidyl-histidine modification (GO:0018202) | 3.29583103 |
| 66 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.24647697 |
| 67 | fucose catabolic process (GO:0019317) | 3.24358133 |
| 68 | L-fucose metabolic process (GO:0042354) | 3.24358133 |
| 69 | L-fucose catabolic process (GO:0042355) | 3.24358133 |
| 70 | negative regulation of muscle contraction (GO:0045932) | 3.22675042 |
| 71 | replicative senescence (GO:0090399) | 3.12613892 |
| 72 | sphingolipid catabolic process (GO:0030149) | 3.10048729 |
| 73 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.05180652 |
| 74 | regulation of interleukin-8 secretion (GO:2000482) | 3.04303689 |
| 75 | neuromuscular synaptic transmission (GO:0007274) | 3.02949878 |
| 76 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.02539799 |
| 77 | L-ascorbic acid metabolic process (GO:0019852) | 3.00164569 |
| 78 | snRNA transcription (GO:0009301) | 2.96397465 |
| 79 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.95305973 |
| 80 | histone H3-K36 demethylation (GO:0070544) | 2.95134176 |
| 81 | activin receptor signaling pathway (GO:0032924) | 2.93461405 |
| 82 | tryptophan metabolic process (GO:0006568) | 2.92615909 |
| 83 | regulation of respiratory gaseous exchange (GO:0043576) | 2.92003932 |
| 84 | regulation of telomerase activity (GO:0051972) | 2.90686663 |
| 85 | auditory receptor cell stereocilium organization (GO:0060088) | 2.90501896 |
| 86 | mitochondrial genome maintenance (GO:0000002) | 2.88663318 |
| 87 | regulation of protein deacetylation (GO:0090311) | 2.86647505 |
| 88 | oxidative demethylation (GO:0070989) | 2.83113381 |
| 89 | positive regulation of heat generation (GO:0031652) | 2.82529887 |
| 90 | polyol biosynthetic process (GO:0046173) | 2.81733502 |
| 91 | regulation of thymocyte apoptotic process (GO:0070243) | 2.79381646 |
| 92 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.77332575 |
| 93 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.74471631 |
| 94 | membrane lipid catabolic process (GO:0046466) | 2.73916641 |
| 95 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.72133847 |
| 96 | indole-containing compound metabolic process (GO:0042430) | 2.71045960 |
| 97 | negative regulation of macroautophagy (GO:0016242) | 2.68794195 |
| 98 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 11.4442826 |
| 99 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 11.4442826 |
| 100 | behavioral response to nicotine (GO:0035095) | 10.1252474 |
RPL23P2 
